- Supported exchanges /
- NSE /
- INDSWFTLAB.NSE
Ind-Swift Laboratories Limited (INDSWFTLAB NSE) stock market data APIs
Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is headquartered in Manimajra, India.
Ind-Swift Laboratories Limited Financial Data Overview
98.63 | |
98.63 | |
- | |
98.63 | |
98.63 | |
89.5-186 | |
5 897 M | |
1.5608 | |
59 087 K | |
10 037 M | |
0.265 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Ind-Swift Laboratories Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 10 037 M
- EBITDA 1 968 M
- Earnings Per Share 63.19
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Ind-Swift Laboratories Limited Earnings via APIs
- Latest Release 2024-11-05
- EPS/Forecast NaN
Get Ind-Swift Laboratories Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: